论文部分内容阅读
目的:分析与总结临床药师参与感染性疾病患者抗感染治疗方案治疗效果的实践与体会,为临床药师参与临床合理用药提供参考。方法:选取2013年1月—2014年12月间临床药师参与感染性疾病会诊记录,分析患者性别、年龄、会诊科室、菌群分布、感染部位、会诊意见采纳率和治疗效果等。结果:在采纳的263例会诊病例中,60岁以上的老年患者110例占41.82%,肺部感染患者153例占58.18%;会诊意见采纳率为91.57%;主要部分采纳率为4.76%,未被采纳率为3.67%;采纳会诊意见病例的有效治疗率为82.89%。结论:临床药师参与抗感染用药方案的制订,在药学监护中发挥重要作用。
Objective: To analyze and summarize the practice and experience of clinical pharmacists participating in the anti-infective treatment in patients with infectious diseases, and provide reference for clinical pharmacists to participate in clinical rational drug use. Methods: From January 2013 to December 2014, clinical pharmacists participated in the consultation records of infectious diseases, and analyzed the gender, age, consultation department, distribution of bacteria, infection site, consultation rate and treatment effect. Results: In the 263 cases of consultation, 110 cases of elderly patients over 60 accounted for 41.82%, 153 cases of lung infection accounted for 58.18%; Consultation Adopted rate was 91.57%; The main part of the adoption rate of 4.76%, not The adopted rate was 3.67%. The effective treatment rate of adopting the consultation cases was 82.89%. Conclusion: The participation of clinical pharmacists in the formulation of anti-infectives regimen plays an important role in pharmacy care.